Sildenafil and Uteroplacental Perfusion

• Status: Unknown status
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether sildenafil is effective and safe in the treatment of fetal growth restriction.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Tehran University of Medical Sciences
• Treatments: Sildenafil Citrate

Criteria

Inclusion Criteria:

• FGR pregnancies in 24-37 weeks of GA

Exclusion Criteria:

• vasodilator agents usage

• history of cardiovascular morbidity specially of right heart side

• drug or alcohol abusers

• systolic BP more than 210 mm Hg or diastolic BP more than 120 mm Hg